B
Catalyst Pharmaceuticals, Inc. CPRX
$21.02 $0.150.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 491.73M 460.48M 434.48M 411.35M 398.20M
Total Other Revenue -- -- -- -- --
Total Revenue 491.73M 460.48M 434.48M 411.35M 398.20M
Cost of Revenue 70.62M -17.84M 57.43M 55.04M 53.45M
Gross Profit 421.11M 478.32M 377.04M 356.31M 344.76M
SG&A Expenses 177.74M 175.58M 163.26M 150.93M 133.71M
Depreciation & Amortization 37.38M 37.09M 36.23M 35.38M 32.57M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 296.61M 286.51M 348.60M 333.02M 311.39M
Operating Income 195.12M 173.97M 85.88M 78.33M 86.81M
Income Before Tax 216.26M 188.79M 93.56M 86.29M 94.51M
Income Tax Expenses 52.37M 45.99M 25.41M 21.17M 23.10M
Earnings from Continuing Operations 163.89 142.80 68.15 65.12 71.41
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 163.89M 142.80M 68.15M 65.12M 71.41M
EBIT 195.12M 173.97M 85.88M 78.33M 86.81M
EBITDA 232.90M 211.43M 122.45M 114.04M 119.69M
EPS Basic 1.38 1.24 0.58 0.59 0.67
Normalized Basic EPS 1.11 1.01 0.50 0.47 0.54
EPS Diluted 1.31 1.18 0.54 0.54 0.61
Normalized Diluted EPS 1.05 0.95 0.46 0.43 0.49
Average Basic Shares Outstanding 473.81M 460.63M 448.27M 436.35M 425.10M
Average Diluted Shares Outstanding 499.75M 487.22M 468.38M 457.40M 447.98M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings